these 16 patients were compared historically to 84 patients with hematological malignancy receiving cyclophosphamide ( 120 mg/kg ) , fractionated total body irradiation ( 12 or 14 gy ) , oral cyclosporin , and unmanipulated hla-identical sibling marrow , for parameters of engraftment and graft-versus-host disease ( gvhd ) .
C0010592
cyclosporin
C0018133
graft-versus-host disease